2007
DOI: 10.1016/j.pt.2007.07.003
|View full text |Cite
|
Sign up to set email alerts
|

Attenuated vaccines for tropical theileriosis, babesiosis and heartwater: the continuing necessity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
71
0
1

Year Published

2009
2009
2023
2023

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 82 publications
(72 citation statements)
references
References 47 publications
0
71
0
1
Order By: Relevance
“…It is not inconceivable that the shared characteristics of Babesia and Plasmodium may make genetically modified Babesia an attractive agent for delivery of live antimalaria vaccines. Such thoughts are encouraged by the fact that Babesia has been successfully used as an attenuated vaccine in veterinary applications (42).…”
Section: Cd14mentioning
confidence: 99%
“…It is not inconceivable that the shared characteristics of Babesia and Plasmodium may make genetically modified Babesia an attractive agent for delivery of live antimalaria vaccines. Such thoughts are encouraged by the fact that Babesia has been successfully used as an attenuated vaccine in veterinary applications (42).…”
Section: Cd14mentioning
confidence: 99%
“…It causes high mortalities in sheep, goats, and cattle and is of major economic importance to livestock production and development in sub-Saharan Africa and on several Caribbean islands (28,36,44). Different vaccines with various efficacies have been produced against E. ruminantium, including live organisms followed by antibiotic (infection and treatment), live-attenuated vaccines, whole-organism inactivated vaccines, and recombinant protein and DNA vaccines (13,24,32,41). Although many of the vaccines have conferred at least partial protection, a continuing problem is breakthrough infection on challenge with organisms heterologous to those included in the vaccines.…”
mentioning
confidence: 99%
“…Since its inception about 50 years ago, attempts based on the inactivated (Martinez et al, 1996) and attenuated live vaccines (Mahan et al, 1998;Shkap et al, 2007) gave some success but not good enough to replace it. The hope for an effective and stable vaccine shifted to genomics and proteomics to deliver a non-living vaccine that can also be used in rural areas where infrastructures are limited (Mwangi et al, 2002).…”
Section: Discussionmentioning
confidence: 99%